Search
for
Sort by
Research 211–240 of 1000+
- Lupus erythematosus: systemic and cutaneous manifestations
- Physiologic skin changes in pregnancy
- Nutrition and Hair
- Ubiquity and Diversity of Human-Associated Demodex Mites
- From Telogen to Exogen: Mechanisms Underlying Formation and Subsequent Loss of the Hair Club Fiber
- Folliculitis
- Polycystic Ovary Syndrome and Its Differential Diagnosis
- Psychodermatology
- Adrenal Disorders and the Paediatric Brain: Pathophysiological Considerations and Clinical Implications
- Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data
- Chaos and antichaos in pathology
- Pregnancy and Skin
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Frontal Fibrosing Alopecia: A Retrospective Analysis of 72 Patients from a German Academic Center
- Change of the diagnostic distribution in applicants to dermatology after COVID ‐19 pandemic: What it whispers to us?
- Distribution of childhood skin diseases according to age and gender, a single institution experience
- AROMA THERAPY: AN ART OF HEALING
- Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects
- IMMUNOPATHOLOGY OF THE HUMAN HAIR FOLLICLE
- Clinical picture of infectious syphilis
- ACUTE ZINC DEPLETION SYNDROME DURING PARENTERAL HYPERALIMENTATION
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Polycystic ovary syndrome: a dermatologic approach
- Psychotropic Medications and the Skin
- Chemical Compatibility and Safety of Imidacloprid/Flumethrin Collar (Seresto®) Concomitantly Used with Imidacloprid/Moxidectin (Advocate®, Advantage® Multi) and Emodepside/Praziquantel (Profender®) Spot-on Formulations
- Heterogeneity of Polymorphous Light Eruption: A Study of 105 Patients
- Taste disorders and alopecia in myasthenia gravis
- Combined therapy with adipose tissue-derived mesenchymal stromal cells and meglumine antimoniate controls lesion development and parasite load in murine cutaneous leishmaniasis caused by Leishmania amazonensis
- Dermatological medications and local therapeutics
- Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database